This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Essilor International. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: Mark Mildebrath: Innovator in Ophthalmic Technology
Introduction
Mark Mildebrath is a notable inventor based in Dallas, TX (US), recognized for his contributions to ophthalmic technology. He holds 2 patents that showcase his innovative approach to multi-layer assemblies and lens treatment systems. His work has significantly impacted the field of optical and ophthalmic articles.
Latest Patents
Mildebrath's latest patents include a "Multi-layer assembly and method for controlling layer thicknesses." This invention describes pre-fabricated assemblies and methods for coating substrates, which involve stacking layers of dielectric materials. The process allows for sequential energy delivery to the exposed layers, facilitating the fabrication of multi-layered coatings for optical applications. Another significant patent is the "Ophthalmic lens treatment system," which formulates optimal treatment plans based on customer orders and available equipment. This system enhances the efficiency of applying treatments to ophthalmic lenses, ensuring high-quality results.
Career Highlights
Mark Mildebrath is currently employed at Essilor International, a leading company in the optical industry. His role involves developing innovative solutions that improve lens treatment processes and enhance product quality. His expertise in multi-layer technology has positioned him as a key player in advancing ophthalmic treatments.
Collaborations
Mildebrath collaborates with talented professionals such as David Thornhill and Brad J Gelb, contributing to a dynamic work environment that fosters innovation and creativity.
Conclusion
Mark Mildebrath's contributions to ophthalmic technology through his patents and work at Essilor International highlight his role as a significant inventor in the field. His innovative solutions continue to shape the future of optical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
